Acorda Looking to Develop New Drugs, CEO Says

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

June 27 (Bloomberg) -- Ron Cohen, chief executive officer of Acorda Therapeutics Inc., talks about the company's products and drug pricing. He speaks with Shannon Pettypiece at the 2011 BIO International Convention in Washington. They speak on Bloomberg Television's "In the Loop." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change